Braidwell LP Keros Therapeutics, Inc. Transaction History
Braidwell LP
- $1.79 Billion
- Q4 2024
A detailed history of Braidwell LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Braidwell LP holds 1,894,439 shares of KROS stock, worth $20.9 Million. This represents 1.68% of its overall portfolio holdings.
Number of Shares
1,894,439
Previous 707,240
167.86%
Holding current value
$20.9 Million
Previous $41.1 Billion
99.93%
% of portfolio
1.68%
Previous 1.16%
Shares
7 transactions
Others Institutions Holding KROS
# of Institutions
177Shares Held
31.1MCall Options Held
646KPut Options Held
670K-
Black Rock Inc. New York, NY2.51MShares$27.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.96MShares$21.6 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.69MShares$18.6 Million2.53% of portfolio
-
State Street Corp Boston, MA1.2MShares$13.3 Million0.0% of portfolio
-
Holocene Advisors, LP New York, NY1.2MShares$13.2 Million0.07% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $284M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...